DR. WILLIAM G. TUCKER
DR. WILLIAM G. TUCKER, (1927-2021) was the founder of the Company. It is from Dr. Tucker’s initial clinical treatment of oncology patients, and through his background, experience and expertise that these drug development projects have taken form. Dr. Tucker has received degrees from both Mount Allison University (B.Sc.) as well as Queen’s School of Medicine (M.D., C.M.). After attending Queen’s in 1958 he held residencies in the Canadian Forces Hospital aboard the H.M.C.S. Stadacoma and at the Henry Ford Hospital in Detroit, Ml. He was a member of the Research Training Staff in the Oncology Department of the Henry Ford Hospital from 1965 until 1969, when he became the Director of the Midwest Oncology Centre in Kalamazoo, Michigan. From 1972 to 1974 he served as the Chief of the Department of Medicine at the Borgess Hospital in Kalamazoo, Michigan. In 1974 he became the Medical Chairman of the American Cancer Society (1974-1976) and served as President of the Michigan Oncology Institute (1978-1981). He was also a founding member of four groups concerned with oncology; The American Society of Clinical Oncology; The Detroit Cancer Club; The International Association for the Study of Lung Cancer; and The Michigan Society of Clinical Oncology. Listed in the Appendix II is his extensive list of abstracts, presentations and publications.
Additionally, Dr. William Tucker authored a medical hypothesis titled “The MSMV Hypothesis: Measles Virus and Multiple Sclerosis, Etiology and Treatment” (2008) which explores the correlation between the measles virus and two neurological disorders, Multiple Sclerosis (MS) and Subacute Sclerosing Panencephalitis (SSPE). (Appendix Ill). Dr. Tucker’s Curriculum Vitae is available upon request.
1996-2001
Dr. Tucker developed the Micro Delivery System (MDS). This is a designed drug delivery system for drugs that are given intravenously, to be able to deliver them by mouth. The MDS will increase the serum level of oral drugs.
2001-2005
Completion of the Science of the Blood Brain Barrier (BBB).
2005-2008
Developed Anti-Viral Drug. Worked also on SSPE and MS evaluations for the patent. Dr. Tucker also continued work on the Cancer Drug and evaluations, preparing to be ready to patent.
2008-2011
Completion of the Pathophysiology of the Measles Virus – (etiology of MS). Dr. Tucker applied for patents on Anti-Viral Drug and Cancer Drug.
2011-2016
The MS etiology and treatment completed by 2012. The science of Cancer was completed in early 2016.
Applied for Patents:
Anti-Viral – 2009
Cancer – 2010
Patents Received:
Anti-Viral – 2014
Cancer – 2014